A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery

NCT05459220 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 357

Last updated 2022-07-14

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy and safety of SHR0410 injection for the treatment of pain after laparoscopic surgery

Conditions

  • Postoperative Pain Of Laparoscopic Surgery

Interventions

DRUG

SHR0410 Injection

SHR0410 Injection(Low Dose)

DRUG

SHR0410 Injection

SHR0410 Injection(High Dose)

DRUG

Placebo

Placebo for SHR0410 Injection.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-02-28
Completion
2023-02-28

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459220 on ClinicalTrials.gov